FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/11/097232 [Registered on: 11/11/2025] Trial Registered Prospectively
Last Modified On: 08/11/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Dentistry 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   This study aims to determine if albumin-enhanced PRF block can serve as a more biologically effective alternative to conventional guided tissue regeneration for regenerating bone in intrabony defects using a modified minimally invasive surgery approach. 
Scientific Title of Study   Comparative evaluation of conventional guided tissue regeneration to albumin-platelet rich fibrin block for the management of intrabony defects via modified-minimally invasive surgical technique:A clinicoradiographic study 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Bhoomika K V 
Designation  Post Graduate Student 
Affiliation  Bapuji Dental college and Hospital 
Address  Bapuji Dental college and hospital, Department of Periodontology Room no.5 MCC B block ,577004 davnagere Davanagere KARNATAKA 577004 India

Davanagere
KARNATAKA
577004
India 
Phone  8073655543  
Fax    
Email  bhoomikv01@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Raison Thomas 
Designation  Professor 
Affiliation  Bapuji Dental College and Hospital 
Address  Bapuji Dental College and Hospital, Department of Periodontology Room no.5 MCC B block ,577004 Davangere

Davanagere
KARNATAKA
577004
India 
Phone  9886279018  
Fax    
Email  drrais79@yahoo.co.in  
 
Details of Contact Person
Public Query
 
Name  Bhoomika K V 
Designation  Post Graduate Student 
Affiliation  Bapuji Dental college and Hospital 
Address  bapuji dental college and hospital, Department of Periodontology Room no.5 MCC B block ,577004 davnagere Davanagere KARNATAKA 577004 India

Davanagere
KARNATAKA
577004
India 
Phone  8073655543  
Fax    
Email  bhoomikv01@gmail.com  
 
Source of Monetary or Material Support  
NIL 
 
Primary Sponsor  
Name  Bhoomika K V 
Address  Bapuji Dental college and hospital,mcc b block ,577004 davnagere  
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Bhoomika K V  Bapuji dental college and hospital  bapuji dental college and hospital, Department of Periodontology Room no.5 mcc b block ,577004 davnagere Davanagere KARNATAKA 577004 India
Davanagere
KARNATAKA 
08073655543

bhoomikv01@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
institutional review board  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K053||Chronic periodontitis,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Albumin-PRF block using M-MIST.  To obtain the Alb-PRF block, blood will be collected from the centre cubital vein in the 9ml S-PRF tube without any additive. Following collection, it will be put in the centrifuge with a water-filled tube to keep the balance while centrifuging for eight minutes at 2700 rpm (~700 x g). For ten minutes, the syringe containing platelet deficient plasma (PPP) will be heated to between 70 and 75 degrees Celsius. The syringe will be allowed to cool for an additional ten minutes at room temperature following the completion of the heating process. Next, the cooled albumin gel will be combined with liquid PRF (i-PRF), which includes the remaining cells and growth factors present in the buffy coat layer, to create Alb-PRF. After mixing, the finished product will be placed in a glass container and blended gently with tweezers. By combining chopped Alb-PRF membrane with particulate bone graft (Xenograft), an Alb-PRF block will be produced. The block that forms after the fibrin polymerization process (about five minutes) has been identified as an Alb-PRF block.  
Intervention  Conventional GTR using M-MIST   An entrance horizontal internal bevel incision will be made buccally at the base of the interdental papilla using a 15C blade. Without affecting the nearby papillae, intrasulcular incisions will be used to connect the interdental incision to the buccal face of the teeth that border the defect. Minimal elevation of a triangular buccal flap will be performed by carefully dissecting the gingiva in order to reveal the remaining buccal bony crest without any reflection of the affected papilla. Following the buccal reflection, the supracrestal interdental tissue will be separated from the granulation tissue using a 15C blade aimed at the buccal surface of the lingual bone wall. Curettes will subsequently be used to eliminate the granulation tissue. The root surface will undergo extensive scaling and root planing. Following M-MIST preparation, a particulate bone graft material (Xenograft) will be used and the intrabony defects will be covered with a resorbable collagen membrane after the defect has been filled. 
 
Inclusion Criteria  
Age From  25.00 Year(s)
Age To  55.00 Year(s)
Gender  Both 
Details  1.Systemically healthy subjects who are not disqualified for periodontal surgery.
2.Subjects with good oral hygiene.
Site specific:
1. Individuals with radiographic evidence of bone defect (2 wall/3 wall/Grade II furcation involvement) and localized Stage III Grade B periodontitis.
2. In addition to having an intrabony 2 or 3wall defect of 4–7 mm, subjects should have a clinical attachment level and probing depth more than 4 mm.
 
 
ExclusionCriteria 
Details  1.Individuals who smoke more than ten cigarettes a day as a chronic smoker.
2. Individuals who are unavailable for additional testing.
3. Pregnant and nursing mothers as subjects.
4. Participants who, within the previous six months, had received any kind of surgical periodontal therapy.
 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Other 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
Percentage changes in defect fill, alveolar crest ,defect width, defect angle   at baseline and 4 months after surgery  
 
Secondary Outcome  
Outcome  TimePoints 
Plaque Index, Gingival Index, probing depth of the pocket, clinical attachment level  at baseline and 4 months after surgery 
 
Target Sample Size   Total Sample Size="16"
Sample Size from India="16" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3/ Phase 4 
Date of First Enrollment (India)   16/11/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="9"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

The main objective of periodontal regeneration is to encourage the formation of new bone and create a new cementum with the periodontal ligament (PDL) fiber connected to the alveolar bone. The process of restoring periodontal tissue by utilizing a membrane that acts as an occlusive barrier between PDL tissue and gingival and alveolar bone. GTR is thought to be the ideal approach for preventing the migration of connective and epithelial tissues through the site of surgery. Platelet-rich fibrin (PRF), an autologous platelet concentrate contains several growth factors that are essential for better wound healing. The success of autologous platelet concentrates in some surgical operations may be hampered by restrictions in fibrin mesh in vivo lifetime, despite the fact that different regimens are designed for particular therapeutic applications. A method for creating albumin-enriched platelet-rich fibrin was developed to overcome this restriction.

As far as we are aware, till date no study has been done to compare and assess the clinical and radiographic aspects of conventional GTR against Alb-PRF block using M-MIST technique in the management of intraosseous discrepancies in the periodontal region in patients with localized stage III grade B periodontitis

 
Close